Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aripiprazole for Methamphetamine Dependence
NCT00728312Phase 4Withdrawn
- Sponsor
- United States Department of Veterans Affairs
- Start
- Aug 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Aripiprazole with Placebo (2 arms). Primary endpoint: Reduction in methamphetamine use as measured weekly by the Time Line Follow Back (TLFB) and Urine Drug Screens at 12 weeks. Planned start Aug 2009; status: withdrawn.
02
Drugs
aripiprazole
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00728312.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00728312.